Cannell & Co. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 211 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cannell & Co. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$159,000
+65.6%
10,2000.0%0.01%
+25.0%
Q3 2020$96,000
+5.5%
10,2000.0%0.00%0.0%
Q2 2020$91,000
+40.0%
10,2000.0%0.00%
+33.3%
Q1 2020$65,000
-55.8%
10,200
-67.9%
0.00%
-40.0%
Q3 2016$147,000
-20.1%
31,7500.0%0.01%
-28.6%
Q2 2016$184,000
-4.2%
31,7500.0%0.01%0.0%
Q1 2016$192,000
+111.0%
31,750
+217.5%
0.01%
+133.3%
Q4 2015$91,00010,0000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders